DexCom, Inc. (DXCM) Hit 1-Year High at $80.70 on May, 3

May 3, 2018 - By Ronnie Lemelle

DexCom, Inc. (NASDAQ:DXCM) Corporate Logo

During 2017 Q4 the big money sentiment decreased to 0.73. That’s change of 0.24, from 2017Q3’s 0.97. 44 investors sold all, 97 reduced holdings as DexCom, Inc. ratio dived. 55 increased positions while 48 funds bought positions. Funds hold 99.11 million shares thus 0.83% more from 2017Q3’s 98.30 million shares.
20,050 were accumulated by Patten Patten Tn. National Bank Of America Corporation De accumulated 303,988 shs. Gp One Trading Lp stated it has 10,952 shs. 94,868 are owned by Lmr Prtn Limited Liability Partnership. Hsbc Public Ltd Com owns 5,823 shs for 0% of their capital. The France-based Tobam has invested 0% in DexCom, Inc. (NASDAQ:DXCM). 3,630 were reported by Da Davidson Commerce. Products Lc holds 559,400 shs. Tennessee-based Highland Capital Limited Liability Corporation has invested 0.03% in DexCom, Inc. (NASDAQ:DXCM). Essex Mngmt Ltd Liability accumulated 29,477 shs or 0.22% of the stock. Granite Invest Prns Lc reported 169,705 shs or 0.61% of all its holdings. Citadel Advsr Limited holds 0% or 59,987 shs. Rhumbline Advisers accumulated 0.01% or 101,761 shs. Chevy Chase Tru Inc reported 0.01% in DexCom, Inc. (NASDAQ:DXCM). Tirschwell And Loewy owns 2.27% invested in DexCom, Inc. (NASDAQ:DXCM) for 280,545 shs.

DexCom, Inc. had 10 insider sales and 0 buys since December 11, 2017. This’s net activity of $3.61 million. The insider SAYER KEVIN R sold 6,000 shs worth $353,092. On Monday, April 23 Shares for $188,649 were sold by DOUBLEDAY RICHARD. On Monday, December 11 the insider Balo Andrew K sold $198,691.

Today DexCom, Inc. (NASDAQ:DXCM) with $80.70 price per share, reached one-year high with $85.54 price target or 6.00 % above. On May, 3 it was reported by DexCom, Inc. (NASDAQ:DXCM) has $7.02B market cap. $421.26M more could be NASDAQ:DXCM valuation at $85.54 share price.

The stock increased 8.60% or $6.39 during the last trading session, hitting $80.7.DexCom, Inc. is downtrending after having declined 16.08% since May 3, 2017. DXCM has 2.54M volume or 125.50% up from normal. DXCM underperformed by 27.63% the S&P 500.

DexCom, Inc. (NASDAQ:DXCM) Ratings Coverage

In total 10 analysts cover Dexcom (NASDAQ:DXCM). “Buy” rating has 7, “Sell” are 2, while 1 are “Hold”. (NASDAQ:DXCM) has 70% bullish analysts. With $86 highest and $57 lowest price target, Dexcom has $73.50 average price target or -8.92% below the current ($80.7) price. 17 are the (NASDAQ:DXCM)’s ratings reports on May 3, 2018 according to StockzIntelligence Inc. On Wednesday, February 28 Canaccord Genuity maintained DexCom, Inc. (NASDAQ:DXCM) with “Buy” rating. The company rating was maintained by Cowen & Co on Wednesday, December 20. On Thursday, January 4 the stock of DexCom, Inc. (NASDAQ:DXCM) earned “Underperform” rating by Northland Capital. In Thursday, December 21 report Jefferies maintained the stock with “Buy” rating. In Wednesday, March 28 report Canaccord Genuity maintained the stock with “Buy” rating. On Wednesday, March 28 the stock of DexCom, Inc. (NASDAQ:DXCM) earned “Buy” rating by Cowen & Co. On Friday, March 23 the firm has “Buy” rating given by Piper Jaffray. On Monday, April 9 the rating was maintained by Stephens with “Buy”. On Thursday, May 3 BMO Capital Markets maintained DexCom, Inc. (NASDAQ:DXCM) rating. BMO Capital Markets has “Outperformer” rating and $86 target. On Wednesday, January 17 BMO Capital Markets maintained the shares of DXCM in report with “Buy” rating.

DexCom, Inc., a medical device company, focuses on the design, development, and commercialization of continuous glucose monitoring systems in the United States and internationally.The firm is valued at $7.02 billion. The firm offers its systems for ambulatory use by people with diabetes; and for use by healthcare providers.Last it reported negative earnings. The Company’s products include DexCom G5 mobile continuous glucose monitoring system to communicate directly to patient's mobile device; DexCom G4 PLATINUM system for continuous use by adults with diabetes; and DexCom Share, a remote monitoring system.

DexCom, Inc. (NASDAQ:DXCM) Institutional Investors Chart

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.

Free Email Newsletter

Enter your email address below to get the latest news and analysts' ratings for your stocks with our free daily email newsletter: